Compare CPSS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPSS | OSUR |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.1M | 177.2M |
| IPO Year | 1992 | 1986 |
| Metric | CPSS | OSUR |
|---|---|---|
| Price | $9.42 | $2.51 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 20.4K | ★ 775.4K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $196,531,000.00 | $125,703,000.00 |
| Revenue This Year | $139.62 | N/A |
| Revenue Next Year | $10.58 | $3.70 |
| P/E Ratio | $11.89 | ★ N/A |
| Revenue Growth | ★ 6.67 | N/A |
| 52 Week Low | $6.67 | $2.08 |
| 52 Week High | $12.73 | $4.22 |
| Indicator | CPSS | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 68.21 | 50.54 |
| Support Level | $9.17 | $2.41 |
| Resistance Level | $9.73 | $2.65 |
| Average True Range (ATR) | 0.30 | 0.10 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 87.94 | 50.88 |
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.